0001209191-21-039571.txt : 20210610
0001209191-21-039571.hdr.sgml : 20210610
20210610172457
ACCESSION NUMBER: 0001209191-21-039571
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210608
FILED AS OF DATE: 20210610
DATE AS OF CHANGE: 20210610
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paul Robert
CENTRAL INDEX KEY: 0001757964
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38792
FILM NUMBER: 211009050
MAIL ADDRESS:
STREET 1: C/O ALECTOR, INC.
STREET 2: 151 OYSTER POINT BLVD., #300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Alector, Inc.
CENTRAL INDEX KEY: 0001653087
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462702363
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 151 OYSTER POINT BLVD., SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 415-231-5660
MAIL ADDRESS:
STREET 1: 151 OYSTER POINT BLVD., SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: Alector LLC
DATE OF NAME CHANGE: 20150915
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-08
0
0001653087
Alector, Inc.
ALEC
0001757964
Paul Robert
C/O ALECTOR, INC.
131 OYSTER POINT BLVD, SUITE 600
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Medical Officer
Common Stock
2021-06-08
4
M
0
7292
8.16
A
281011
D
Common Stock
2021-06-08
4
M
0
11883
10.14
A
292894
D
Common Stock
2021-06-08
4
S
0
16175
19.0004
D
276719
D
Common Stock
2021-06-08
4
S
0
2200
19.8877
D
274519
D
Common Stock
2021-06-08
4
S
0
800
20.8263
D
273719
D
Employee Stock Option (right to buy)
8.16
2021-06-08
4
M
0
7292
0.00
D
2028-07-02
Common Stock
7292
115083
D
Employee Stock Option (right to buy)
10.14
2021-06-08
4
M
0
11883
0.00
D
2028-11-06
Common Stock
11883
42284
D
The sales reported by the Reporting Person were effected pursuant to a Rule 10b5-1 trading plan adopted on May 28, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.61 to $19.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3) and (4).
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.63 to $20.59, inclusive.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.64 to $21.08, inclusive.
One forty-eighth (1/48th) of the shares subject to the option vested on August 2, 2018, and one forty-eighth (1/48th) of the shares subject to the option vest monthly thereafter.
One-fourth (1/4th) of the shares subject to the option vested on November 1, 2019 and one forty-eighth (1/48th) of the shares vest monthly thereafter.
/s/ David Oh, attorney-in-fact
2021-06-10